Literature DB >> 22252879

Nonhuman primate model of pertussis.

Jason M Warfel1, Joel Beren, Vanessa K Kelly, Gloria Lee, Tod J Merkel.   

Abstract

Pertussis is a highly contagious, acute respiratory illness caused by the bacterial pathogen Bordetella pertussis. Despite nearly universal vaccine coverage, pertussis rates in the United States have been rising steadily over the last 20 years. Our failure to comprehend and counteract this important public health concern is due in large part to gaps in our knowledge of the disease and the mechanisms of vaccine-mediated protection. Important questions about pertussis pathogenesis and mechanisms of vaccine effectiveness remain unanswered due to the lack of an animal model that replicates the full spectrum of human disease. Because current animal models do not meet these needs, we set out to develop a nonhuman primate model of pertussis. We inoculated rhesus macaques and olive baboons with wild-type B. pertussis strains and evaluated animals for clinical disease. We found that only 25% of rhesus macaques developed pertussis. In contrast, 100% of inoculated baboons developed clinical pertussis. A strong anamnestic response was observed when convalescent baboons were infected 6 months following recovery from a primary infection. Our results demonstrate that the baboon provides an excellent model of clinical pertussis that will allow researchers to investigate pertussis pathogenesis and disease progression, evaluate currently licensed vaccines, and develop improved vaccines and therapeutics.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22252879      PMCID: PMC3318410          DOI: 10.1128/IAI.06310-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis.

Authors:  J Taranger; B Trollfors; T Lagergård; V Sundh; D A Bryla; R Schneerson; J B Robbins
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

2.  Adenylate cyclase toxin from Bordetella pertussis: current concepts and problems in the study of toxin functions.

Authors:  E L Hewlett; K J Kim; S J Lee; M C Gray
Journal:  Int J Med Microbiol       Date:  2000-10       Impact factor: 3.473

3.  Kinetics of the IgG antibody response to pertussis toxin after infection with B. pertussis.

Authors:  P F M Teunis; O G van der Heijden; H E de Melker; J F P Schellekens; F G A Versteegh; M E E Kretzschmar
Journal:  Epidemiol Infect       Date:  2002-12       Impact factor: 2.451

4.  Pertussis vaccines: WHO position paper.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2010-10-01

5.  Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine.

Authors:  Tine Dalby; Jesper Westphal Petersen; Zitta B Harboe; Karen Angeliki Krogfelt
Journal:  J Med Microbiol       Date:  2010-05-27       Impact factor: 2.472

Review 6.  Duration of immunity against pertussis after natural infection or vaccination.

Authors:  Aaron M Wendelboe; Annelies Van Rie; Stefania Salmaso; Janet A Englund
Journal:  Pediatr Infect Dis J       Date:  2005-05       Impact factor: 2.129

7.  Pertussis epidemiology in Australia over the decade 1995-2005--trends by region and age group.

Authors:  Helen E Quinn; Peter B McIntyre
Journal:  Commun Dis Intell Q Rep       Date:  2007-06

8.  Problem solved: a modified enzyme-linked immunosorbent assay for detection of human antibodies to pertussis toxin eliminates false-positive results occurring at analysis of heat-treated sera.

Authors:  Tine Dalby; Maria Seier-Petersen; Max Per Kristiansen; Zitta Barrella Harboe; Karen Angeliki Krogfelt
Journal:  Diagn Microbiol Infect Dis       Date:  2009-02-26       Impact factor: 2.803

9.  Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.

Authors:  J Storsaeter; H O Hallander; L Gustafsson; P Olin
Journal:  Vaccine       Date:  1998-12       Impact factor: 3.641

Review 10.  The benefits of using diverse animal models for studying pertussis.

Authors:  Shokrollah Elahi; James Holmstrom; Volker Gerdts
Journal:  Trends Microbiol       Date:  2007-10-24       Impact factor: 17.079

View more
  59 in total

Review 1.  Bordetella pertussis transmission.

Authors:  Elizabeth A Trainor; Tracy L Nicholson; Tod J Merkel
Journal:  Pathog Dis       Date:  2015-09-14       Impact factor: 3.166

Review 2.  Bordetella pertussis evolution in the (functional) genomics era.

Authors:  Thomas Belcher; Andrew Preston
Journal:  Pathog Dis       Date:  2015-08-21       Impact factor: 3.166

3.  Unraveling the challenges of pertussis.

Authors:  Kathryn M Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-31       Impact factor: 11.205

4.  Waning Immunity and Microbial Vaccines-Workshop of the National Institute of Allergy and Infectious Diseases.

Authors:  Xin-Xing Gu; Stanley A Plotkin; Kathryn M Edwards; Alessandro Sette; Kingston H G Mills; Ofer Levy; Andrea J Sant; Annie Mo; William Alexander; Kristina T Lu; Christopher E Taylor
Journal:  Clin Vaccine Immunol       Date:  2017-07-05

5.  Modulation of Pertussis and Adenylate Cyclase Toxins by Sigma Factor RpoE in Bordetella pertussis.

Authors:  Mariette Barbier; Dylan T Boehm; Emel Sen-Kilic; Claire Bonnin; Theo Pinheiro; Casey Hoffman; Mary Gray; Erik Hewlett; F Heath Damron
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

6.  Airborne transmission of Bordetella pertussis.

Authors:  Jason M Warfel; Joel Beren; Tod J Merkel
Journal:  J Infect Dis       Date:  2012-07-17       Impact factor: 5.226

7.  Development of a novel preclinical model of pneumococcal pneumonia in nonhuman primates.

Authors:  Bryan D Kraft; Claude A Piantadosi; Ashlee M Benjamin; Joseph E Lucas; Aimee K Zaas; Marisol Betancourt-Quiroz; Christopher W Woods; Alan L Chang; Victor L Roggli; Craig D Marshall; Geoffrey S Ginsburg; Karen Welty-Wolf
Journal:  Am J Respir Cell Mol Biol       Date:  2014-05       Impact factor: 6.914

8.  Maternal and neonatal vaccination protects newborn baboons from pertussis infection.

Authors:  Jason M Warfel; James F Papin; Roman F Wolf; Lindsey I Zimmerman; Tod J Merkel
Journal:  J Infect Dis       Date:  2014-02-12       Impact factor: 5.226

9.  Role of Major Toxin Virulence Factors in Pertussis Infection and Disease Pathogenesis.

Authors:  Karen Scanlon; Ciaran Skerry; Nicholas Carbonetti
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

10.  Quantification of the adenylate cyclase toxin of Bordetella pertussis in vitro and during respiratory infection.

Authors:  Joshua C Eby; Mary C Gray; Jason M Warfel; Christopher D Paddock; Tara F Jones; Shandra R Day; James Bowden; Melinda D Poulter; Gina M Donato; Tod J Merkel; Erik L Hewlett
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.